Millennium Management »

Lexeo Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.7M 594k 14.70
2023-12-31 $592k 44k 13.42

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Put Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices Call Option (AMD)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Broadcom (AVGO)

View all positions for Millennium Management

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics